[Risk factors for recurrence after intravitreal anti-vascular endothelial growth factor injection for retinopathy of prematurity].

Qing-Fei Hao,Jing Chen, Peng Ruan, Gao-Pan Li, Jing Zhang,Hao-Ming Chen,Hong-Xiang Guo, Xiao-Juan Sun,Xiu-Yong Cheng

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics(2022)

Cited 0|Views2
No score
Abstract
Intravitreal anti-VEGF injection is effective for ROP. Preoperative fundus hemorrhage and long duration of oxygen therapy may increase the risk of ROP recurrence, and further studies are needed to investigate the influence of gestational hypertension on the recurrence of ROP.
More
Translated text
Key words
Anti-vascular endothelial growth factor,Preterm infant,Recurrence,Retinopathy of prematurity
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined